Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07694206 · ClinicalTrials.gov registry record
Digital and Plasma Biomarkers in Delirium
A clinical trial, sponsored by Scripps Health.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07694206 is a clinical trial that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 100 participants.
The verdict
NCT07694206 is actively recruiting participants, sponsored by Scripps Health.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn if there are potential digital and plasma-based biomarkers that could help detect, predict, and prognosticate delirium in older adult patients who are admitted to the intensive care unit (ICU). The main question DELTA aims to answer is: Can digital biometrics predict and detect delirium in older adult ICU patients? Do biomarkers of neurodegeneration fluctuate in ICU patients in such a way that delrium could potentially be predicted? Participants admitted o the ICU will wear a digital device to collect biometric data and will have serial plasma samples collected during ICU admission and patients will be also assessed for delirium daily by study staff.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07694206
The ClinicalTrials.gov registry entry for NCT07694206 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07694206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07694206 about?
NCT07694206 is a clinical study titled "Digital and Plasma Biomarkers in Delirium". The goal of this observational study is to learn if there are potential digital and plasma-based biomarkers that could help detect, predict, and prognosticate delirium in older adult patients who are admitted to the intensive care unit (ICU). The main question DELTA aims to answer is: Can digital b...
What is the current status of trial NCT07694206?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-05-28. Estimated completion is 2027-12-31.
Who is sponsoring clinical trial NCT07694206?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.